ライフサイエンスコーパス: human granulocytic ehrlichiosis

1 uses human anaplasmosis (previously known as human granulocytic ehrlichiosis).

2 hils and causes human anaplasmosis (formerly human granulocytic ehrlichiosis).

3 is an appropriate substrate for identifying human granulocytic ehrlichiosis.

4 pathogen was responsible for both equine and human granulocytic ehrlichiosis.

5 e home of an individual with prior confirmed human granulocytic ehrlichiosis.

6 an granulocytotropic ehrlichia, the agent of human granulocytic ehrlichiosis.

7 tory intragranulocytic bacterium that causes human granulocytic ehrlichiosis.

8 racellular bacterium of granulocytes, causes human granulocytic ehrlichiosis.

9 ins of Ehrlichia phagocytophila, an agent of human granulocytic ehrlichiosis.

10 he same tick that transmits Lyme disease and human granulocytic ehrlichiosis.

11 s were tested for antibodies to the agent of human granulocytic ehrlichiosis.

12 ion caused by E. chaffeensis or the agent of human granulocytic ehrlichiosis.

13 sis, E. sennetsu, E. canis, and the agent of human granulocytic ehrlichiosis.

14 specific for E. chaffeensis or the agent of human granulocytic ehrlichiosis.

15 Anaplasma phagocytophilum causes the disease human granulocytic ehrlichiosis.

16 with clinical presentations compatible with human granulocytic ehrlichiosis.

17 A human-derived strain of the agent of human granulocytic ehrlichiosis, a recently described em

18 -like illness; human monocytic ehrlichiosis; human granulocytic ehrlichiosis; a novel cat flea-associ

19 The human granulocytic ehrlichiosis agent (HGEa) survives ex

20 This paper describes the kinetics of the human granulocytic ehrlichiosis agent in the blood of ho

21 isolates of Ehrlichia equi in horses and two human granulocytic ehrlichiosis agent isolates in Califo

22 hods with 5 strains of Ehrlichia equi or the human granulocytic ehrlichiosis agent to assess the suit

23 mbrane proteins of Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) are encoded by th

24 The human granulocytic ehrlichiosis agent, Anaplasma phagocy

25 -bp target amplicon from E. chaffeensis, the human granulocytic ehrlichiosis agent, or Ehrlichia muri

26 f E. equi, Ehrlichia phagocytophila, and the human granulocytic ehrlichiosis agent.

27 nis and Ehrlichia chaffeensis but not in the human granulocytic ehrlichiosis agent.

28 tients had detectable antibodies against the human granulocytic ehrlichiosis agent; however, only 2 h

29 The agent of human granulocytic ehrlichiosis (Anaplasma phagocytophil

30 gene reported to differ between the agent of human granulocytic ehrlichiosis and closely related spec

31 s a surrogate substrate for the detection of human granulocytic ehrlichiosis and should be used solel

32 ar organism Anaplasma phagocytophilum causes human granulocytic ehrlichiosis and specifically infects

33 Human anaplasmosis (formerly human granulocytic ehrlichiosis) and human monocytic ehr

34 The p44 gene of the agent of human granulocytic ehrlichiosis (aoHGE) encodes a 44-kDa

35 nity interrupts transmission of the agent of human granulocytic ehrlichiosis (aoHGE) to guinea pigs.

36 Population kinetics of the agent of human granulocytic ehrlichiosis (aoHGE) were examined af

37 coinfection among rodents with the agent of human granulocytic ehrlichiosis (aoHGE).

38 ansmission of the agents of Lyme disease and human granulocytic ehrlichiosis by individual ticks was

39 s of Lyme disease (Borrelia burgdorferi) and human granulocytic ehrlichiosis (Ehrlichia phagocytophil

40 nogroup II ehrlichia, including the agent of human granulocytic ehrlichiosis, Ehrlichia phagocytophil

41 n with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis have been documented.

42 nsmission of a human isolate of the agent of human granulocytic ehrlichiosis (HGE agent) from infecte

43 ains) and Western blot analyses containing a human granulocytic ehrlichiosis (HGE) agent (NCH-1 strai

44 led two genotypes of A. phagocytophilum, the human granulocytic ehrlichiosis (HGE) agent and a varian

45 seroreactivity to a cultured isolate of the human granulocytic ehrlichiosis (HGE) agent by using an

46 ns from a cell culture isolate (USG3) of the human granulocytic ehrlichiosis (HGE) agent has identifi

47 with low and high passage of in vitro-grown human granulocytic ehrlichiosis (HGE) agent in horses.

48 The human granulocytic ehrlichiosis (HGE) agent in infected

49 A 44-kDa major outer membrane protein of the human granulocytic ehrlichiosis (HGE) agent is an immuno

50 of human monocytes and macrophages, and the human granulocytic ehrlichiosis (HGE) agent is an obliga

51 oma (n = 1), and Marin (n = 1) counties, and human granulocytic ehrlichiosis (HGE) agent isolates wer

52 The human granulocytic ehrlichiosis (HGE) agent resides and

53 ests using the 16S rRNA gene, the DNA of the human granulocytic ehrlichiosis (HGE) agent was detected

54 A human granulocytic ehrlichiosis (HGE) agent with 16S rDN

55 The human granulocytic ehrlichiosis (HGE) agent, which repli

56 major outer membrane proteins (OMPs) of the human granulocytic ehrlichiosis (HGE) agent, with molecu

57 equi, is closely related or identical to the human granulocytic ehrlichiosis (HGE) agent.

58 ify patients with antibodies reactive to the human granulocytic ehrlichiosis (HGE) agent.

59 E. equi, E. phagocytophila, and the agent of human granulocytic ehrlichiosis (HGE) amplified DNA from

60 evaluated as a method for early detection of human granulocytic ehrlichiosis (HGE) and determination

61 lification of whole blood from patients with human granulocytic ehrlichiosis (HGE) and from infected

62 The early antibody response in patients with human granulocytic ehrlichiosis (HGE) and in mice infect

63 Human granulocytic ehrlichiosis (HGE) and Lyme borrelios

64 The natural reservoirs for the agent of human granulocytic ehrlichiosis (HGE) are suspected to b

65 Lyme disease and human granulocytic ehrlichiosis (HGE) are tick-borne ill

66 ed from persons who were suspected of having human granulocytic ehrlichiosis (HGE) but who lacked ant

67 The ank gene of the agent of human granulocytic ehrlichiosis (HGE) codes for a protei

68 Antibodies in the sera of patients with human granulocytic ehrlichiosis (HGE) commonly recognize

69 with ehrlichiae isolated from a patient with human granulocytic ehrlichiosis (HGE) developed anemia a

70 The incidence of human granulocytic ehrlichiosis (HGE) in the upper Midwe

71 Human granulocytic ehrlichiosis (HGE) is a febrile tick-

72 Human granulocytic ehrlichiosis (HGE) is a newly describ

73 The agent of human granulocytic ehrlichiosis (HGE) is a newly recogni

74 Human granulocytic ehrlichiosis (HGE) is a potentially f

75 Human granulocytic ehrlichiosis (HGE) is a tickborne ill

76 Human granulocytic ehrlichiosis (HGE) is an emerging feb

77 Human granulocytic ehrlichiosis (HGE) is an emerging inf

78 Human granulocytic ehrlichiosis (HGE) is an emerging tic

79 Human granulocytic ehrlichiosis (HGE) is an emerging tic

80 The agent of human granulocytic ehrlichiosis (HGE) is an emerging tic

81 Human granulocytic ehrlichiosis (HGE) is an emerging tic

82 Human granulocytic ehrlichiosis (HGE) is an emerging tic

83 Human granulocytic ehrlichiosis (HGE) is an emerging tic

84 The etiologic agent of human granulocytic ehrlichiosis (HGE) is an obligate int

85 The agent of human granulocytic ehrlichiosis (HGE) is an obligate int

86 Human granulocytic ehrlichiosis (HGE) is caused by an ag

87 Human granulocytic ehrlichiosis (HGE) is caused by infec

88 Human granulocytic ehrlichiosis (HGE) is usually diagnos

89 ses of human monocytic ehrlichiosis (HME) or human granulocytic ehrlichiosis (HGE) may be made on the

90 Human granulocytic ehrlichiosis (HGE) results in fever,

91 Previous studies of human granulocytic ehrlichiosis (HGE) suggest a role for

92 (NOS2(-/-)) were infected with the agent of human granulocytic ehrlichiosis (HGE) to evaluate the im

93 The cytokine response to the agent of human granulocytic ehrlichiosis (HGE) was assessed in a

94 is required for transmission of the agent of human granulocytic ehrlichiosis (HGE) was determined by

95 etection of human antibodies to the agent of human granulocytic ehrlichiosis (HGE) was developed and

96 cytoplasmic vacuoles containing the agent of Human Granulocytic Ehrlichiosis (HGE) was studied to inv

97 Serum samples from patients with confirmed human granulocytic ehrlichiosis (HGE) were tested for cy

98 R targeting of the p44 genes of the agent of human granulocytic ehrlichiosis (HGE) with primers flank

99 of immune status in a murine model system of human granulocytic ehrlichiosis (HGE), C3H/HeJ, C3H-SCID

100 equi, Ehrlichia phagocytophila, the agent of human granulocytic ehrlichiosis (HGE), Ehrlichia canis,

101 The agent of human granulocytic ehrlichiosis (HGE), Ehrlichia phagocy

102 The agent of human granulocytic ehrlichiosis (HGE), Ehrlichia phagocy

103 es to Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis (HGE), in different grou

104 tent hallmark of infection with the agent of human granulocytic ehrlichiosis (HGE), regardless of hos

105 In patients with human granulocytic ehrlichiosis (HGE), the HGE agent has

106 sis, which is caused by Babesia microti, and human granulocytic ehrlichiosis (HGE), which is caused b

107 ied as human monocytic ehrlichiosis (HME) or human granulocytic ehrlichiosis (HGE).

108 ta for infection with the etiologic agent of human granulocytic ehrlichiosis (HGE).

109 e sera of 24 patients with culture-confirmed human granulocytic ehrlichiosis (HGE).

110 hiae, Ehrlichia chaffeensis and the agent of human granulocytic ehrlichiosis (HGE).

111 at cause an acute, life-threatening illness, human granulocytic ehrlichiosis (HGE).

112 terial pathogens, in particular the agent of human granulocytic ehrlichiosis (HGE).

113 s define the MSP2 homologues in the agent of human granulocytic ehrlichiosis (HGE).

114 We describe the cultivation of the agent of human granulocytic ehrlichiosis in cell culture.

115 Sera from 35 patients diagnosed with human granulocytic ehrlichiosis in Connecticut were test

116 ction between the agents of Lyme disease and human granulocytic ehrlichiosis in I. scapularis ticks.

117 ed the agent to be identical to the agent of human granulocytic ehrlichiosis in Minnesota and Wiscons

118 sed to identify the first recognized case of human granulocytic ehrlichiosis in Rhode Island.

119 the New York State Department of Health for human granulocytic ehrlichiosis in the residents of West

120 mptoms and laboratory findings suggestive of human granulocytic ehrlichiosis, including unexplained f

121 The agent of human granulocytic ehrlichiosis infects mostly neutrophi

122 Human granulocytic ehrlichiosis is a potentially fatal t

123 Human granulocytic ehrlichiosis is an emerging infectiou

124 Human granulocytic ehrlichiosis is being increasingly re

125 iosis is caused by Ehrlichia chaffeensis and human granulocytic ehrlichiosis is caused by an agent si

126 these results for the molecular diagnosis of human granulocytic ehrlichiosis is discussed.

127 lasma phagocytophila, the etiologic agent of human granulocytic ehrlichiosis, is an emerging bacteria

128 sp from Wolbachia sp., p44 from the agent of human granulocytic ehrlichiosis, msp-2 and msp-4 from An

129 f ehrlichia in neutrophils, was positive for human granulocytic ehrlichiosis on PCR.

130 Current antibody testing for human granulocytic ehrlichiosis relies predominantly on

131 In contrast, the risk of acquiring human granulocytic ehrlichiosis remains minimal despite

132 pathogens that cause bovine anaplasmosis and human granulocytic ehrlichiosis, respectively.

133 asma phagocytophilum, the causative agent of human granulocytic ehrlichiosis, results in downregulati

134 ed laboratory-reared ticks with the agent of human granulocytic ehrlichiosis, suggesting that these r

135 Anaplasma phagocytophilum causes human granulocytic ehrlichiosis, the second most common

136 blood specimens from patients with confirmed human granulocytic ehrlichiosis (three from New York, fo

137 The causative agent of human granulocytic ehrlichiosis was recently reclassifie

138 from Ehrlichia phagocytophila (the agent of human granulocytic ehrlichiosis), was evaluated by class